HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase II trial

M.I. van Poelgeest; M.J. Welters; E.M. van Esch; L.F. Stynenbosch; G. Kerpershoek; E.L. van Persijn-van Meerten; M. van den Hende; M.J. Lowik; D.M. Berends-van Meer; L.M. Fathers; A.R. Valentijn; J. Oostendorp; G.J. Fleuren; C.J. Melief; G.G. Kenter; S.H. van der Burg

doi:10.1186/1479-5876-11-88

HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase II trial

M.I. van Poelgeest, M.J. Welters, E.M. van Esch, L.F. Stynenbosch, G. Kerpershoek, E.L. van Persijn-van Meerten, M. van den Hende, M.J. Lowik, D.M. Berends-van Meer, L.M. Fathers, A.R. Valentijn, J. Oostendorp, G.J. Fleuren, C.J. Melief, G.G. Kenter, S.H. van der Burg

Obstetrics and gynaecology

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Article number	88
Journal	Journal of Translational Medicine
Volume	11
DOIs	https://doi.org/10.1186/1479-5876-11-88
Publication status	Published - 2013

Access to Document

10.1186/1479-5876-11-88

Cite this

van Poelgeest, M. I., Welters, M. J., van Esch, E. M., Stynenbosch, L. F., Kerpershoek, G., van Persijn-van Meerten, E. L., ... van der Burg, S. H. (2013). HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase II trial. Journal of Translational Medicine, 11, [88]. https://doi.org/10.1186/1479-5876-11-88

van Poelgeest, M.I. ; Welters, M.J. ; van Esch, E.M. ; Stynenbosch, L.F. ; Kerpershoek, G. ; van Persijn-van Meerten, E.L. ; van den Hende, M. ; Lowik, M.J. ; Berends-van Meer, D.M. ; Fathers, L.M. ; Valentijn, A.R. ; Oostendorp, J. ; Fleuren, G.J. ; Melief, C.J. ; Kenter, G.G. ; van der Burg, S.H. / HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase II trial. In: Journal of Translational Medicine. 2013 ; Vol. 11.

@article{0dbafbdda98641b4954a6c60f58241b2,

title = "HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase II trial",

author = "{van Poelgeest}, M.I. and M.J. Welters and {van Esch}, E.M. and L.F. Stynenbosch and G. Kerpershoek and {van Persijn-van Meerten}, E.L. and {van den Hende}, M. and M.J. Lowik and {Berends-van Meer}, D.M. and L.M. Fathers and A.R. Valentijn and J. Oostendorp and G.J. Fleuren and C.J. Melief and G.G. Kenter and {van der Burg}, S.H.",

year = "2013",

doi = "10.1186/1479-5876-11-88",

language = "Undefined/Unknown",

volume = "11",

journal = "Journal of Translational Medicine",

issn = "1479-5876",

publisher = "BioMed Central",

}

van Poelgeest, MI, Welters, MJ, van Esch, EM, Stynenbosch, LF, Kerpershoek, G, van Persijn-van Meerten, EL, van den Hende, M, Lowik, MJ, Berends-van Meer, DM, Fathers, LM, Valentijn, AR, Oostendorp, J, Fleuren, GJ, Melief, CJ, Kenter, GG & van der Burg, SH 2013, 'HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase II trial', Journal of Translational Medicine, vol. 11, 88. https://doi.org/10.1186/1479-5876-11-88

HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase II trial. / van Poelgeest, M.I.; Welters, M.J.; van Esch, E.M.; Stynenbosch, L.F.; Kerpershoek, G.; van Persijn-van Meerten, E.L.; van den Hende, M.; Lowik, M.J.; Berends-van Meer, D.M.; Fathers, L.M.; Valentijn, A.R.; Oostendorp, J.; Fleuren, G.J.; Melief, C.J.; Kenter, G.G.; van der Burg, S.H.

In: Journal of Translational Medicine, Vol. 11, 88, 2013.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase II trial

AU - van Poelgeest, M.I.

AU - Welters, M.J.

AU - van Esch, E.M.

AU - Stynenbosch, L.F.

AU - Kerpershoek, G.

AU - van Persijn-van Meerten, E.L.

AU - van den Hende, M.

AU - Lowik, M.J.

AU - Berends-van Meer, D.M.

AU - Fathers, L.M.

AU - Valentijn, A.R.

AU - Oostendorp, J.

AU - Fleuren, G.J.

AU - Melief, C.J.

AU - Kenter, G.G.

AU - van der Burg, S.H.

PY - 2013

Y1 - 2013

U2 - 10.1186/1479-5876-11-88

DO - 10.1186/1479-5876-11-88

M3 - Article

C2 - 23557172

VL - 11

JO - Journal of Translational Medicine

JF - Journal of Translational Medicine

SN - 1479-5876

M1 - 88

ER -